SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53.

@article{Kim2011SIRT1AB,
  title={SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53.},
  author={Duk Hoon Kim and Yu Jin Jung and Jung Eun Lee and Ae Sin Lee and Kyung Pyo Kang and Sik Lee and Sung Kwang Park and Myung-Kwan Han and Sang Yong Lee and K. M. Ramkumar and Mi Jeong Sung and Won Kim},
  journal={American journal of physiology. Renal physiology},
  year={2011},
  volume={301 2},
  pages={
          F427-35
        }
}
  • D. KimY. Jung Won Kim
  • Published 1 August 2011
  • Biology, Chemistry
  • American journal of physiology. Renal physiology
Nephrotoxicity is one of the important dose-limiting factors during cisplatin treatment. There is a growing body of evidence that activation of p53 has a critical role in cisplatin-induced renal apoptotic injury. The nicotinamide adenine dinucleotide-dependent protein deacetylase SIRT1 decreases apoptosis through deacetylating of p53, and resveratrol is known as an activator of SIRT1. To study the role of SIRT1 in cisplatin-induced renal injury through interaction with p53, mouse proximal… 
View on PubMed
ajprenal.physiology.org
155 Citations
Highly Influential Citations
8
Background Citations
67
Methods Citations
3
Results Citations
3

Figures from this paper

155 Citations

SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells.

Pharmacological Activation of Sirt1 Ameliorates Cisplatin-Induced Acute Kidney Injury by Suppressing Apoptosis, Oxidative Stress, and Inflammation in Mice

It is found that SRT1720 treatment ameliorated cisplatin-induced acute renal failure and histopathological alterations and showed that the therapeutic effects of S RT1720 were associated with reduced acetylation of p53 and nuclear factor kappa-B p65 and preservation of peroxisome function, as evidenced by recovered expression of markers for number and function of peroxideisome.

Pioglitazone alleviates cisplatin nephrotoxicity by suppressing mitochondria‐mediated apoptosis via SIRT1/p53 signalling

Results implied PIO attenuated cisplatin nephrotoxicity by suppressing mitochondria‐mediated apoptosis through regulating SIRT1/p53 signalling.

Absence of Sirt3 aggravates cisplatin nephrotoxicity via enhanced renal tubular apoptosis and inflammation

The results of the present study suggested that Sirt3 may have an important role in cisplatin-induced nephrotoxicity, and aggravated in renal injury by increasing renal inflammation and tubular apoptosis.

Inhibition of p300 by Garcinol Protects against Cisplatin-Induced Acute Kidney Injury through Suppression of Oxidative Stress, Inflammation, and Tubular Cell Death in Mice

It is demonstrated that the inhibition of p300 by garcinol ameliorated cisplatin-induced renal injury, presumably through epigenetic mechanisms, and suggest that garinol might be a potential preventive agent for cisplarin-induced AKI.

The modulation of sirtuins by natural compounds in the management of cisplatin-induced nephrotoxicity.

It has been shown that sirtuins can exert a protective effect on cisplatin-induced acute kidney injury by targeting multiple signaling pathways and not only did not reduce the anticancer effect of cisPlatin but also increased it.

Inhibiting microRNA-449 Attenuates Cisplatin-Induced Injury in NRK-52E Cells Possibly via Regulating the SIRT1/P53/BAX Pathway

Results indicate that inhibiting miR-449 allows the attenuation of cisplatin-induced injury in NRK-52E cells, suggesting that miR -449 is a potential target for treating AKI.

Protective effect of the BET protein inhibitor JQ1 in cisplatin-induced nephrotoxicity.

The results suggest that JQ1 may protect against cisplatin nephrotoxicity by suppressing DNA damage response, p53, MAP kinases, and oxidative/nitrosative stress pathways.

P53 Contributes to Cisplatin Induced Renal Oxidative Damage via Regulating P66shc and MnSOD

Background/Aims: Cisplatin is widely used to treat malignancies. However, its major limitation is the development of dose-dependent nephrotoxicity. The precise mechanisms of cisplatin-induced kidney…

P2X7 receptor blockade protects against cisplatin-induced nephrotoxicity in mice by decreasing the activities of inflammasome components, oxidative stress and caspase-3.

...

References

SHOWING 1-10 OF 35 REFERENCES

Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells.

The results suggest that inhibitors of histone deacetylases can protect against cisplatin nephrotoxicity by attenuating DNA damage response and associated p53 activation.

Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.

The first compelling evidence is demonstrated for the involvement of PUMA-alpha in p53-mediated renal cell apoptosis during cisplatin nephrotoxicity, and the inductive response was abrogated in p 53-deficient animals.

Activation and involvement of p53 in cisplatin-induced nephrotoxicity.

The involvement of p53 in cisplatin-induced renal cell apoptosis and nephrotoxicity is suggested, which limits its use and efficacy in cancer treatment.

Kidney-specific Overexpression of Sirt1 Protects against Acute Kidney Injury by Retaining Peroxisome Function

Results indicate that Sirt1 overexpression in proximal tubules rescues cisplatin-induced AKI by maintaining peroxisomes number and function, concomitant up-regulation of catalase, and elimination of renal ROS levels.

Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways.

It is demonstrated that at least 50% of cisplatin-induced apoptosis in RPTC is mediated by p53 and that p53 activates caspase 3 independently of either caspases 9 or 8 or mitochondrial dysfunction.

SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2

It is suggested that SIRT inhibitors require combined targeting of both SIRT1 and SIRT2 to induce p53 acetylation and cell death and that p53 mediates the cytotoxic function of Sirtinol and Salermide.

Role of p 53 in cisplatin-induced tubular cell apoptosis : dependence on p 53 transcriptional activity

An important role is found for p53 in cisplatin-induced apoptosis in renal tubular cells and the results suggest that p53 activation might be an early signal for apoptosis during cisPlatin treatment.

Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase

It is demonstrated that SIRT1, a nicotinamide adenosine dinucleotide‐dependent histone deacetylase, regulates the transcriptional activity of NF‐κB and activity augments apoptosis in response to TNFα.

siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury.

Data indicate that rapid delivery of siRNA to proximal tubule cells follows intravenous administration, suggesting potential therapeutic benefit for ischemic and nephrotoxic kidney injury.

P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor.

It is concluded that p53 is an important mediator of apoptosis during states of GTP depletion and inhibitors of p53 should be considered in the treatment of ischemic renal injury.